Latin America Newborn Screening Market Size & Outlook
Latin America newborn screening market, 2018-2030 (US$M)
Related Markets
Latin America newborn screening market highlights
- The Latin America newborn screening market generated a revenue of USD 100.6 million in 2023.
- The market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 100.6 million |
| Market revenue in 2030 | USD 155.4 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, Latin America region accounted for 12.6% of the global newborn screening market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 451.1 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.65% in 2023. Horizon Databook has segmented the Latin America newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
The coverage rate for screening in newborn varies across the 20 countries of Latin America. 100% coverage is observed in Chile, Cuba, and Uruguay, and countries such as El Salvador, Haiti, and Honduras have negligible coverage. Congenital hypothyroidism testing is mandated in ten countries, whereas phenylketonuria testing is compulsory only in Costa Rica, Paraguay, Brazil, Venezuela, Guatemala, and Chile.
However, parents can demand for additional testing depending on the need. Recently, emphasis on cystic fibrosis and hearing screen has gained momentum across the region. In 2012, World Solutions Against Infectious Diseases (WSAID) announced partnership with Save Babies Through Screening Foundation (SBTS) and work for expansion of the screening program with the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America newborn screening market size, by country, 2018-2030 (US$M)
Latin America Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
